Dana McAfee Hammill

Dana Hammill is a highly accomplished professional with a diverse educational background and extensive experience in the biotechnology and business sectors. Dana holds a Master of Biotechnology (MB) in Gene/Genetic Therapy from the University of Pennsylvania, a Master of Business Administration (M.B.A.) in Leadership from Saint Joseph's University, as well as various certificates in negotiation and management from top institutions like Harvard Law School and the Wharton School. Dana completed a Bachelor of Science (BS) in Biotechnology at Rutgers University, showcasing a strong foundation in the field. Dana has held key roles in several prominent organizations, including being the Co-Founder and COO at DeCART Therapeutics. Prior to that, Dana served as the President at RnR Biomedical Solutions and worked in strategic business development at the University of Pennsylvania. Dana has also contributed to academia as a Professor at Thomas Edison State College and has held various leadership positions focusing on patient safety, consultancy, and program management in the biotechnology and research fields. With a rich tapestry of experiences and a robust educational background, Dana Hammill is a seasoned professional poised to make significant contributions in the biotechnology and business arenas.